Fingerprint
Dive into the research topics where Menno van Nimwegen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 48 Article
-
Evidence for altered immune-structural cell crosstalk in cystic fibrosis revealed by single cell transcriptomics
Berg, M., Krabbendam, L., van der Ploeg, E. K., van Nimwegen, M., van der Veer, T., Banchero, M., Carpaij, O. A., Hoogenboezem, R., van den Berge, M., Bindels, E., Aerts, J. G. J. V., Collin, A., Barbry, P., Kamphuis, L. S., Hendriks, R. W., Nawijn, M. C. & Stadhouders, R., 13 Feb 2025, (E-pub ahead of print) In: Journal of Cystic Fibrosis. 24, 5, p. 849-860 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile32 Downloads (Pure) -
Aberrant characteristics of peripheral blood innate lymphoid cells in COPD, independent of smoking history
van Zelst, C. M., In ’T Veen, J. C. C. M., Krabbendam, L., de Boer, G. M., de Bruijn, M. J. W., van Nimwegen, M., van der Ploeg, E. K., van Uden, D., Stadhouders, R., Tramper-Stranders, G. A., Hendriks, R. W. & Braunstahl, G. J., 1 Jan 2024, In: ERJ Open Research. 10, 1, 00652-2023.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Citations (Scopus)26 Downloads (Pure) -
Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations
van der Ploeg, E. K., Krabbendam, L., Vroman, H., van Nimwegen, M., de Bruijn, M. J. W., de Boer, G. M., Bergen, I. M., Kool, M., Tramper-Standers, G. A., Braunstahl, G. J., Huylebroeck, D., Hendriks, R. W. & Stadhouders, R., 23 Aug 2023, In: Nature Communications. 14, 1, 5137.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile38 Citations (Scopus)38 Downloads (Pure) -
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
van Gulijk, M., van Krimpen, A., Schetters, S., Eterman, M., van Elsas, M., Mankor, J., Klaase, L., de Bruijn, M., van Nimwegen, M., van Tienhoven, T., van Ijcken, W., Boon, L., van der Schoot, J., Verdoes, M., Scheeren, F., van der Burg, S. H., Lambrecht, B. N., Stadhouders, R., Dammeijer, F. & Aerts, J. & 1 others, , 19 May 2023, In: Science immunology. 8, 83, eabn6173.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile79 Citations (Scopus)98 Downloads (Pure) -
Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy
Dammeijer, F., van Gulijk, M., Klaase, L., van Nimwegen, M., Bouzid, R., Hoogenboom, R., Joosse, M. E., Hendriks, R. W., van Hall, T. & Aerts, J. G., 6 Sept 2022, In: Molecular Cancer Therapeutics. 21, 9, p. 1393-1405 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access8 Citations (Scopus)